Zacks Equity Research, on Monday July 25, 2011, 5:20 pm EDT We cover Verisante Technology Inc. (VRS.V / VRSEF) with an Outperform rating. See below for free access to our 23-page report on the company in which we detail the size of the skin cancer markets (in the U.S., Europe, Canada and Australia) and how